Checked Nov 5, 2026Start a new check

What was checked

Regulators (including Health Canada, FDA, CDC) were handed evidence of SV40 DNA sequences in Pfizer’s COVID vaccine (from monkey virus known to cause tumors in lab animals) but did nothing, kept reviews secret for years, and continued approvals despite undisclosed contamination.

Assessment summary

Needs caution

FDA and Health Canada publicly assessed the issue and stated that the relevant residual DNA was controlled, inactive, and not a safety concern. Regulators continued authorizations while treating the material as residual, nonfunctional DNA below applicable limits, not as undisclosed infectious contamination. EMA said the plasmid sequence had been provided in the original application, although the SV40 portion was not specifically highlighted because it was considered nonfunctional.

Key findings

Model assessments

Assessment summary

  • The claim combines a verified finding of non-infectious SV40-derived DNA fragments in Pfizer’s manufacturing starting material or residual DNA with unsupported allegations of undisclosed contamination, secret reviews, and regulatory inaction.
  • FDA and Health Canada stated that no infectious SV40 virus or SV40 proteins are present, and that the detected fragment was inactive and below applicable limits.pfizer.com fda.gov science.feedback.org

Claims reviewed

Regulators did nothing after receiving the evidence.

Contradicted
FDA and Health Canada publicly assessed the issue and stated that the relevant residual DNA was controlled, inactive, and not a safety concern.fda.gov science.feedback.org

This claim may mislead readers without added context.

The SV40 DNA came from a monkey virus known to cause tumors in laboratory animals.

Needs context
SV40 is a monkey virus, but the Pfizer product does not contain infectious SV40 virus or SV40 proteins. The detected sequences were non-infectious, nonfunctional fragments, and authorities reported no evidence linking them to increased cancer risk.pfizer.com fda.gov science.feedback.org

This claim may mislead readers without added context.

Health Canada, FDA, and CDC were handed evidence of SV40 DNA sequences in Pfizer’s COVID vaccine.

Needs context
Health Canada and FDA acknowledged SV40-derived sequence information or fragments, but the available sources do not establish that CDC received evidence or that the material constituted infectious SV40 contamination. The relevant sequence was described as a nonfunctional fragment or part of plasmid starting material.fda.gov science.feedback.org factcheck.org

This claim may mislead readers without added context.

Assessment summary

  • The claim contains significant factual errors and misleading framing.
  • While regulators did become aware of SV40 DNA sequences in Pfizer's vaccine, the claim mischaracterizes what was found and how regulators responded.
  • The vaccines do not contain the SV40 virus itself—only inactive DNA fragments.
  • Regulators did not "do nothing"; Health Canada actively recommended removal and continued to monitor.

Claims reviewed

Regulators did nothing

Contradicted
Health Canada actively recommended removal of the SV40 sequences in 2023 and rejected Pfizer's justification for keeping them. The EMA and FDA also acknowledged the sequences. This contradicts the claim that regulators 'did nothing.'

This claim may mislead readers without added context.

Regulators were handed evidence of SV40 DNA sequences

Needs context
Regulators became aware of SV40 sequences, but Pfizer did not explicitly disclose them initially. Health Canada confirmed that Pfizer provided the full plasmid sequence but did not specifically identify the SV40 element within it.

This claim may mislead readers without added context.

Continued approvals despite undisclosed contamination

Needs context
While regulators continued approvals, the characterization is misleading. The SV40 fragment is not harmful according to regulatory assessments. Health Canada stated the fragment is 'inactive, has no functional role, and was measured to be consistently below the limit required by regulators.'

This claim may mislead readers without added context.

Assessment summary

  • There is evidence that short SV40 regulatory DNA fragments were detected as residual DNA in Pfizer/BioNTech vaccine material and that regulators were made aware.
  • However, claims that regulators "did nothing," kept reviews "secret for years," or that contamination was wholly "undisclosed" are misleading because agencies have publicly responded and conducted or referenced reviews.
  • The overall set mixes accurate facts with overstated or unsupported assertions.

Claims reviewed

Regulators kept reviews secret for years

Needs context
Some internal communications and reviews were not immediately public, but agencies later released statements or FOI/response documents; characterizing this as "secret for years" overstates the public timeline. assets.publishing.service.gov.uk source unavailable

This claim may mislead readers without added context.

Regulators did nothing

Needs context
Regulators (e.g., Health Canada, FDA) investigated, issued statements, and considered residual DNA limits and risk assessments rather than taking no action; several agencies publicly reported their determinations. factcheck.org fda.gov

This claim may mislead readers without added context.

Regulators continued approvals despite undisclosed contamination

Needs context
Regulatory authorizations for Pfizer vaccines remained in place, but the presence of short SV40 promoter fragments was acknowledged by agencies (e.g., Health Canada) and described as residual, inactive, and below relevant limits; it was not wholly undisclosed to regulators. factcheck.org factcheck.afp.com fda.gov

This claim may mislead readers without added context.

Sources cited

18 sources

Share this result